GLIPR2 and cancer: Our findings elucidated a discernible positive correlation of GLIPR2 with most immunomodulatory elements across various cancers, including kidney papillary cell carcinoma (KIRC), OV, pan-kidney cohort (KIPAN), LIHC, BRCA, LUAD, THCA, PAAD and BLCA (Supplementary Figure S3; Supplementary Tables S6, S7).